Patent details

EP2928477 Title: USE OF THE TELOMERASE INHIBITOR IMETELSTAT FOR THE TREATMENT OF MYELOFIBROSIS

Basic Information

Publication number:
EP2928477
PCT Application Number:
US2013070437
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP138610084
PCT Publication Number:
WO2014088785
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF THE TELOMERASE INHIBITOR IMETELSTAT FOR THE TREATMENT OF MYELOFIBROSIS
French Title of Invention:
UTILISATION DE L'INHIBITEUR DE TÉLOMÉRASE IMETELSTAT POUR LE TRAITEMENT DE LA MYELOFIBROSE
German Title of Invention:
VERWENDUNG VOM TELOMERASEINHIBITOR IMETELSTAT ZUR BEHANDLUNG VON MYELOFIBROSE
SPC Number:

Dates

Filing date:
15/11/2013
Grant date:
24/07/2019
EP Publication Date:
14/10/2015
PCT Publication Date:
12/06/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2019
EP B1 Publication Date:
24/07/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
15/11/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/03/2020
 
 

Name:
Geron Corporation
Address:
919 E. Hillsdale Blvd., Foster City, CA 94404, United States (US)

History of Owners

From:
17/07/2019
To:
20/03/2020

Name:
Geron Corporation
Address:
149 Commonwealth Drive, Menlo Park, CA 94025, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
31/07/2019
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
KELSEY, Stephen
Address:
United States (US)

2

Name:
STUART, Monic, J.
Address:
United States (US)

Priority

1

Priority Number:
201261734941 P
Priority Date:
07/12/2012
Priority Country:
United States (US)

2

Priority Number:
201313841711
Priority Date:
15/03/2013
Priority Country:
United States (US)

3

Priority Number:
201361799069 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

4

Priority Number:
201361900347 P
Priority Date:
05/11/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/7088; A61K 31/7125; A61P 7/00; A61P 7/06; A61P 35/00; A61P 35/02;

Publication

European Patent Bulletin

1

Issue number:
201930
Publication date:
24/07/2019
Description:
Grant (B1)

2

Issue number:
201935
Publication date:
28/08/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202017
Publication date:
22/04/2020
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
30/11/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/11/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
07/08/2019 Outgoing Correspondence 1
31/07/2019 Power Of Attorney 1